Increased Atherothrombotic Burden in Patients with Diabetes Mellitus and Acute Coronary Syndrome: A Review of Antiplatelet Therapy
Key result
Potent platelet inhibition is of paramount importance to optimize outcomes in patients with diabetes mellitus and acute coronary syndrome due to their increased atherothrombotic risk.
Population
Patients with diabetes mellitus presenting with acute coronary syndrome
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Supports potent antiplatelet consideration in diabetic ACS; leaves optimal regimens and durations open for prospective trials.
Structured PICO
P
Population
Patients with diabetes mellitus presenting with acute coronary syndrome
I
Intervention
Antiplatelet therapies
This review highlights the pathophysiological mechanisms driving increased atherothrombotic risk in diabetic patients with ACS and emphasizes the need for potent antiplatelet therapy to optimize outcomes.
Cite This Study
Balasubramaniam et al. (2012) conducted a review in Diabetes Mellitus and Acute Coronary Syndrome. Antiplatelet therapy was evaluated. Potent platelet inhibition is of paramount importance to optimize outcomes in patients with diabetes mellitus and acute coronary syndrome due to their increased atherothrombotic risk.